China National Accord Medicines Corp Ltd (000028) - Total Assets
Based on the latest financial reports, China National Accord Medicines Corp Ltd (000028) holds total assets worth CN¥50.56 Billion CNY (≈ $7.40 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 000028 net assets for net asset value and shareholders' equity analysis.
China National Accord Medicines Corp Ltd - Total Assets Trend (1992–2024)
This chart illustrates how China National Accord Medicines Corp Ltd's total assets have evolved over time, based on quarterly financial data.
China National Accord Medicines Corp Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
China National Accord Medicines Corp Ltd's total assets of CN¥50.56 Billion consist of 79.0% current assets and 21.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.6% |
| Accounts Receivable | CN¥21.85 Billion | 45.9% |
| Inventory | CN¥7.41 Billion | 15.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥479.54 Million | 1.0% |
| Goodwill | CN¥1.86 Billion | 3.9% |
Asset Composition Trend (1992–2024)
This chart illustrates how China National Accord Medicines Corp Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see China National Accord Medicines Corp Ltd market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: China National Accord Medicines Corp Ltd's current assets represent 79.0% of total assets in 2024, an increase from 45.4% in 1992.
- Cash Position: Cash and equivalents constituted 15.6% of total assets in 2024, down from 33.9% in 1992.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 21.0% in 1992.
- Asset Diversification: The largest asset category is accounts receivable at 45.9% of total assets.
China National Accord Medicines Corp Ltd Competitors by Total Assets
Key competitors of China National Accord Medicines Corp Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
China National Accord Medicines Corp Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.50 | 1.45 | 1.44 |
| Quick Ratio | 1.20 | 1.15 | 1.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥13.71 Billion | CN¥12.59 Billion | CN¥9.00 Billion |
China National Accord Medicines Corp Ltd - Advanced Valuation Insights
This section examines the relationship between China National Accord Medicines Corp Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.78 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | CN¥47.56 Billion |
| Market Capitalization | $1.74 Billion USD |
Valuation Analysis
Below Book Valuation: The market values China National Accord Medicines Corp Ltd's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: China National Accord Medicines Corp Ltd's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for China National Accord Medicines Corp Ltd (1992–2024)
The table below shows the annual total assets of China National Accord Medicines Corp Ltd from 1992 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥47.56 Billion ≈ $6.96 Billion |
-0.03% |
| 2023-12-31 | CN¥47.57 Billion ≈ $6.96 Billion |
+11.63% |
| 2022-12-31 | CN¥42.62 Billion ≈ $6.24 Billion |
-0.39% |
| 2021-12-31 | CN¥42.78 Billion ≈ $6.26 Billion |
+8.05% |
| 2020-12-31 | CN¥39.59 Billion ≈ $5.79 Billion |
+18.12% |
| 2019-12-31 | CN¥33.52 Billion ≈ $4.91 Billion |
+15.87% |
| 2018-12-31 | CN¥28.93 Billion ≈ $4.23 Billion |
+29.48% |
| 2017-12-31 | CN¥22.34 Billion ≈ $3.27 Billion |
+4.84% |
| 2016-12-31 | CN¥21.31 Billion ≈ $3.12 Billion |
+61.24% |
| 2015-12-31 | CN¥13.22 Billion ≈ $1.93 Billion |
+3.04% |
| 2014-12-31 | CN¥12.83 Billion ≈ $1.88 Billion |
+16.02% |
| 2013-12-31 | CN¥11.06 Billion ≈ $1.62 Billion |
+18.96% |
| 2012-12-31 | CN¥9.30 Billion ≈ $1.36 Billion |
+21.26% |
| 2011-12-31 | CN¥7.67 Billion ≈ $1.12 Billion |
+21.55% |
| 2010-12-31 | CN¥6.31 Billion ≈ $922.88 Million |
+20.51% |
| 2009-12-31 | CN¥5.23 Billion ≈ $765.82 Million |
+42.06% |
| 2008-12-31 | CN¥3.68 Billion ≈ $539.08 Million |
+26.77% |
| 2007-12-31 | CN¥2.91 Billion ≈ $425.25 Million |
+8.47% |
| 2006-12-31 | CN¥2.68 Billion ≈ $392.06 Million |
+149.82% |
| 2005-12-31 | CN¥1.07 Billion ≈ $156.93 Million |
+26.74% |
| 2004-12-31 | CN¥846.19 Million ≈ $123.82 Million |
-16.08% |
| 2003-12-31 | CN¥1.01 Billion ≈ $147.55 Million |
-4.21% |
| 2002-12-31 | CN¥1.05 Billion ≈ $154.03 Million |
-5.86% |
| 2001-12-31 | CN¥1.12 Billion ≈ $163.62 Million |
+127.79% |
| 2000-12-31 | CN¥490.89 Million ≈ $71.83 Million |
-8.92% |
| 1999-12-31 | CN¥538.95 Million ≈ $78.87 Million |
-4.16% |
| 1998-12-31 | CN¥562.36 Million ≈ $82.29 Million |
+13.42% |
| 1997-12-31 | CN¥495.82 Million ≈ $72.55 Million |
+11.02% |
| 1996-12-31 | CN¥446.60 Million ≈ $65.35 Million |
+17.46% |
| 1995-12-31 | CN¥380.21 Million ≈ $55.64 Million |
+0.12% |
| 1994-12-31 | CN¥379.76 Million ≈ $55.57 Million |
-1.12% |
| 1993-12-31 | CN¥384.07 Million ≈ $56.20 Million |
+103.29% |
| 1992-12-31 | CN¥188.93 Million ≈ $27.65 Million |
-- |
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Weste… Read more